Skip to content
Trabeculectomy · Tube Shunt · MIGS · Eye treatments

Glaucoma Surgery in Turkey — Trabeculectomy, Tube Shunt and MIGS at Eyeglow Istanbul

Trabeculectomy — the most common glaucoma filtration surgery — together with tube shunt implants (Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant) and minimally invasive glaucoma surgery (MIGS) to lower intraocular pressure when drops and laser are no longer enough. Every case is reviewed by our glaucoma surgical team and operated on by a glaucoma-trained ophthalmic surgeon at our partner accredited hospital. Day-case surgery, written quote and a year of structured IOP and OCT follow-up.

Close-up of a human eye — glaucoma assessment and surgery at Eyeglow Health, Istanbul
Procedure time~45 min
AnaesthesiaLocal or general
Hospital stayDay case (no overnight)
Time in Istanbul5 nights
Success (target IOP)70–90% with medication
Follow-up1 year structured
What it is

What is glaucoma surgery?

Glaucoma surgery lowers intraocular pressure (IOP) to slow or halt damage to the optic nerve when drops and laser are not enough. The most common operation is trabeculectomy, a filtration surgery that creates a guarded drainage channel under the conjunctiva. Tube shunt implants (Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant) are used in complex or refractory eyes, and MIGS (Minimally Invasive Glaucoma Surgery — iStent, Hydrus, XEN gel stent, Kahook Dual Blade) is used in milder disease, often combined with cataract surgery.

At Eyeglow Health in Istanbul, glaucoma surgery is coordinated by our glaucoma surgical team and performed by a glaucoma-trained ophthalmic surgeon at our partner accredited hospital. Surgery takes approximately 45 minutes under local or general anaesthesia, as a day case with no overnight hospital stay. Our pathway is consistent with American Academy of Ophthalmology (AAO) Primary Open-Angle Glaucoma Preferred Practice Pattern and American Glaucoma Society (AGS) consensus.

Glaucoma is a chronic, lifelong condition. Eyeglow can deliver second-opinion review, glaucoma surgery in Istanbul, and a transferable treat-to-target IOP plan — but we are honest that lifelong monitoring is best continued with an ophthalmologist at home. That assessment belongs to a clinician who has personally reviewed your IOP history, optic nerve OCT and visual field — not to a marketing brochure.

How it works

From first consultation to ongoing care

  1. 01

    Online glaucoma review

    You share your most recent intraocular pressure (IOP) measurements, visual field test (Humphrey or Octopus), optic nerve OCT (RNFL and ganglion cell analysis), gonioscopy notes, current eye drop regimen and any prior glaucoma surgery or laser treatment. Our glaucoma surgical team reviews your case and confirms the glaucoma type (primary open-angle, narrow-angle, pigmentary, pseudoexfoliative, secondary), severity and the appropriate surgical step — trabeculectomy, tube shunt or MIGS — before a quote is issued.

  2. 02

    Pre-operative imaging in Istanbul

    On day 1 we repeat IOP (Goldmann applanation, multiple times of day), corneal pachymetry, gonioscopy (anterior chamber angle), optic nerve OCT, visual field test, and anterior segment OCT. These confirm the glaucoma severity and identify the optimal surgical pathway.

  3. 03

    Personalised surgical plan

    Our glaucoma surgical team explains the plan: trabeculectomy — the most common filtration surgery, creating a guarded drainage channel to lower IOP — for most cases where drops and/or laser have not controlled pressure; a tube shunt (Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant) for failed trabeculectomy or complex secondary glaucoma; or a MIGS device (iStent, Hydrus, XEN gel stent, Kahook Dual Blade) for milder disease, often combined with cataract surgery. You sign consent only after every question has been answered.

  4. 04

    The surgery (about 45 minutes)

    Trabeculectomy: under local or general anaesthesia, a partial-thickness scleral flap is created and a small piece of trabecular meshwork is removed, so aqueous humour drains into a controlled filtering bleb under the conjunctiva — antifibrotics (mitomycin C) are applied to keep the channel open. Tube shunt: a silicone tube is implanted to drain aqueous to an equatorial plate reservoir, used in complex or refractory eyes. MIGS: a micro-stent or goniotomy enhances the eye's natural outflow through a 2–3 mm incision, usually combined with cataract surgery. Surgery takes approximately 45 minutes and is performed as a day case — no overnight hospital stay.

  5. 05

    Post-operative reviews in Istanbul

    You are reviewed the morning after surgery and again before flying home. IOP, the bleb (after trabeculectomy) and the anterior chamber are checked at each visit. Mild redness, light sensitivity and a transient IOP change are normal in the first days and managed with topical medication and, after filtering surgery, suture adjustment or bleb needling if required. Most international patients stay around 5 days in Istanbul for the early reviews.

  6. 06

    One-year structured aftercare

    Scheduled reviews at one, three, six and twelve months with IOP measurement, visual field test and optic nerve OCT comparison. Glaucoma is a chronic condition — even after successful surgery, lifelong monitoring is required. We provide a written treat-to-target IOP plan transferable to your home ophthalmologist for ongoing surveillance.

Treatment options

Trabeculectomy vs Tube Shunt vs MIGS

The right operation depends on your glaucoma type, severity and prior treatment. Here is how the three main surgical options differ:

AspectTrabeculectomyTube shuntMIGS
Best forMost cases where drops/laser fail; moderate-to-advanced glaucomaFailed trabeculectomy, neovascular or complex secondary glaucomaMild-to-moderate glaucoma, often combined with cataract surgery
How it worksGuarded drainage channel under the conjunctiva (filtering bleb)Silicone tube drains aqueous to an equatorial plate reservoirMicro-stent or goniotomy enhances natural trabecular outflow
IOP reduction30–50% (to a low target IOP)30–50% (durable in complex eyes)20–35%
Procedure settingOperating theatre, day caseOperating theatre, day caseOperating theatre, day case (often with cataract)
Recovery time2–6 weeks intensive review2–6 weeks intensive review1 week (or per cataract recovery)
Success (target IOP)70–90% with adjunctive medication70–85% in complex/refractory eyes70–80% at 5 years, fewer drops
Pricing

Personalised pricing

Every treatment plan is priced individually after your consultation and imaging review. Request a written, all-inclusive quote — clear, itemised, and with no obligation.

Request a written quote
Package transparency

What's included in your glaucoma surgery package

Included in package

  • Pre-op imaging (IOP, gonioscopy, pachymetry, optic nerve OCT, visual field, anterior segment OCT)
  • Glaucoma consultation + treatment plan review
  • Trabeculectomy / tube shunt / MIGS procedure as planned
  • 5-star hotel — 5 nights
  • VIP airport transfers (return)
  • All post-op drops + aftercare kit
  • Day-1, day-7, 1m, 3m, 6m, 12m IOP and OCT review
  • Written treat-to-target IOP plan for continuation at your home clinic
  • Multilingual glaucoma coordinator — 24/7
  • Complication insurance — covers eligible post-operative medical complications during the recovery period at our partner accredited hospital (issued in line with the Turkish Ministry of Health International Health Tourism Authority Certificate)

Paid separately

Items below are not part of the medical package — your coordinator helps you arrange them at no markup.

  • Flights to/from Istanbul
  • Personal expenses
  • Lifelong glaucoma drops (continued at home, prescribed by your local ophthalmologist)
  • Second glaucoma procedure if needed after 12 months — quoted separately
  • Cataract surgery if standalone (combined cataract + MIGS quoted as bundle above)
  • Unrelated medical treatments
  • Travel insurance (flight cancellation, baggage, general trip cover) — separate from the medical complication policy above; your coordinator can recommend a provider at no markup
Our team

The surgeons who will care for you

Your procedure is carried out by our glaucoma surgical team at our partner accredited hospital in Istanbul. Their training and sub-specialty focus are shown below.

Medically reviewed by Assoc. Prof. Dr. Muhammet Derda Özer, FICO

Candidacy

Are you a candidate for glaucoma surgery?

You may be a good candidate if

  • You have a diagnosis of primary open-angle glaucoma (POAG), narrow-angle glaucoma, pseudoexfoliative or pigmentary glaucoma confirmed by an ophthalmologist with optic nerve OCT and visual field testing.
  • You are intolerant to glaucoma eye drops (allergy, ocular surface disease) or have poor adherence, and your pressure is not adequately controlled — surgery can give more durable IOP control than drops.
  • Your glaucoma is progressing despite maximal eye drops and prior laser treatment — filtration surgery (trabeculectomy or tube shunt) is the indicated next step.
  • You have mild-to-moderate POAG with co-existing cataract — combined cataract + MIGS (iStent, Hydrus) is a single-stage treatment option.
  • You have failed maximal medical therapy or your visual field is progressing despite drops — MIGS or filtering surgery may be needed.

A different pathway may be safer if

  • Advanced glaucoma with end-stage visual field loss — surgical risk outweighs benefit; supportive low-vision care more appropriate.
  • Uncontrolled inflammation, active uveitis or untreated ocular surface disease — must be optimised first.
  • Inability to return for adequate follow-up — glaucoma is a chronic disease requiring lifelong IOP monitoring.
  • Acute angle-closure attack requiring emergency intervention — should be treated in your nearest emergency hospital, not via medical tourism.
  • Pregnancy — elective procedures postponed; some glaucoma medications also need adjustment.

Disclaimer. Information on this page is consistent with American Academy of Ophthalmology (AAO) Primary Open-Angle Glaucoma Preferred Practice Pattern, American Glaucoma Society (AGS) consensus, and FDA approvals of glaucoma surgical devices including iStent (Glaukos 2012), Hydrus (Ivantis 2018), XEN gel stent (Allergan 2016), Kahook Dual Blade (New World Medical 2015) and the Ahmed and Baerveldt glaucoma drainage implants. It is educational and not a clinical recommendation. The only reliable way to know which procedure is right for you is an ophthalmologist-led assessment based on IOP, gonioscopy, optic nerve OCT and visual field testing.

Risks & outcomes

Realistic outcomes — the risks that actually matter

Every glaucoma procedure has measurable risks. We list them here in the same plain language our surgical team uses in your consultation:

Transient IOP change

An early pressure spike or, after filtration surgery, a period of low pressure (hypotony) can occur in the first days — managed with topical medication and, where needed, suture adjustment or bleb needling. We measure IOP at multiple timepoints after surgery and adjust treatment accordingly.

Insufficient IOP reduction

Surgery reaches target IOP in approximately 70 to 90 percent of cases when adjunctive medication is included; the remainder may require additional drops, bleb revision or a further procedure. MIGS gives a 20–35% reduction with fewer drops; trabeculectomy and tube shunts achieve lower target pressures in more advanced disease.

Hyphaema (microscopic bleeding)

Mild anterior chamber bleeding can occur after MIGS, particularly Kahook Dual Blade or stent placement — typically resolves spontaneously within 5 to 7 days. Significant hyphaema requiring intervention is rare (<2%).

Filtering bleb complications (trabeculectomy)

Trabeculectomy adds bleb-specific risks: hypotony (low pressure), bleb leak, bleb infection (blebitis) and late endophthalmitis. These are why milder disease is treated with MIGS where possible and filtration surgery is reserved for cases that need a lower target pressure. With careful surgical technique published complication rates are 5–10%.

FAQ

Frequently asked questions about glaucoma surgery

What is glaucoma?

Glaucoma is a chronic eye disease that damages the optic nerve, usually associated with elevated intraocular pressure (IOP) — although it can occur with normal pressure (normal-tension glaucoma). Damage to the optic nerve causes progressive, irreversible loss of peripheral vision; untreated glaucoma can ultimately cause central vision loss and blindness. Glaucoma is often called the "silent thief of sight" because most types cause no symptoms until significant visual field damage has already occurred. The main types are: primary open-angle glaucoma (POAG, most common), narrow-angle / angle-closure glaucoma, pseudoexfoliative glaucoma, pigmentary glaucoma and secondary glaucoma (after trauma, inflammation or medication). Regular eye examinations with optic nerve OCT and visual field testing are the only way to detect glaucoma early.

What is trabeculectomy?

Trabeculectomy is the most common glaucoma filtration surgery. Under local or general anaesthesia, the surgeon creates a small guarded channel through the sclera (the white of the eye) and removes a tiny piece of trabecular meshwork, so excess aqueous fluid drains into a controlled reservoir under the conjunctiva called a filtering bleb. Antifibrotic medication (mitomycin C) is applied during surgery to stop the channel scarring closed. The operation takes approximately 45 minutes and is performed as a day case — no overnight hospital stay. Trabeculectomy lowers intraocular pressure by 30 to 50 percent and reaches the target pressure in roughly 70 to 90 percent of cases when adjunctive eye drops are included. It is the standard choice when drops and laser have not controlled the pressure.

What is MIGS surgery for glaucoma?

MIGS — Minimally Invasive Glaucoma Surgery — is a family of procedures that lower IOP through small (1 to 2 mm) corneal incisions, with much faster recovery than traditional trabeculectomy or tube shunt surgery. The main FDA-approved MIGS devices are: iStent (Glaukos, 2012) and iStent inject — tiny titanium stents placed in the trabecular meshwork; Hydrus Microstent (Ivantis, 2018) — a longer nitinol stent dilating Schlemm's canal; XEN Gel Stent (Allergan, 2016) — a small subconjunctival gel stent creating a controlled filtration path; and Kahook Dual Blade (New World Medical, 2015) — a goniotomy blade that excises a strip of the trabecular meshwork. Most MIGS procedures are performed in the same operating session as cataract surgery, which makes them an excellent option for patients with both conditions.

What is the difference between trabeculectomy, a tube shunt and MIGS?

They are different operations for different glaucoma situations. (1) Trabeculectomy — the standard filtration surgery, creating a guarded drainage channel into a filtering bleb under the conjunctiva; used in most cases where drops and laser have failed. (2) Tube shunt (Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant) — a silicone tube draining aqueous to an equatorial plate reservoir; used in failed trabeculectomy, neovascular or complex secondary glaucoma. (3) MIGS (iStent, Hydrus, XEN gel stent, Kahook Dual Blade) — minimally invasive micro-stents or goniotomy through a small incision that enhance natural outflow, usually combined with cataract surgery in milder disease. Each has a different indication, recovery profile and risk balance — our glaucoma surgical team recommends the right operation based on your gonioscopy, OCT and visual field.

How long does glaucoma surgery take?

Glaucoma surgery takes approximately 45 minutes. Trabeculectomy and tube shunt implantation are performed in the operating theatre under local or general anaesthesia and take around 45 minutes. MIGS device implantation takes 10 to 30 minutes and is usually combined with cataract surgery. Surgery is a day case — you go home the same day, with no overnight hospital stay. Both eyes are generally not operated on the same day — the second eye, if needed, is scheduled separately so the first eye's pressure response and healing can be monitored first.

What is the success rate of glaucoma surgery?

Success depends on the procedure and how it is defined. (1) Trabeculectomy: target IOP is reached in approximately 70 to 90 percent of cases when adjunctive medication is included, with 60 to 80 percent complete (drop-free) success at 5 years, declining slowly with time (annual failure rate 5 to 10%). (2) Tube shunt (Ahmed, Baerveldt): 70 to 85 percent success at 5 years, particularly durable in complex or refractory eyes. (3) MIGS (iStent, Hydrus): 20 to 35 percent IOP reduction with about 1 drop fewer in medication burden; success at 5 years approximately 70 to 80 percent. The honest measure of "success" in glaucoma is preservation of visual field over decades — not a single IOP measurement on the day of surgery.

What does the glaucoma surgery package include?

Every Eyeglow glaucoma package is priced individually after your consultation — the procedure (trabeculectomy, tube shunt or MIGS) is determined by your gonioscopy, IOP history and optic nerve OCT. All packages include: pre-operative imaging (IOP, gonioscopy, pachymetry, optic nerve OCT, visual field, anterior segment OCT), glaucoma surgical team consultation, the procedure itself, 5-star hotel for 5 nights, VIP airport transfers, post-operative drops and aftercare kit, day-1, day-7, 1m, 3m, 6m and 12m IOP and OCT review, a written treat-to-target IOP plan transferable to your home ophthalmologist, multilingual coordinator, and complication insurance. We use the same Glaukos iStent, Ivantis Hydrus, Allergan XEN gel stent and Ahmed / Baerveldt glaucoma drainage implants used in major glaucoma centres. Request a written itemised quote — no obligation.

Is glaucoma surgery dangerous?

Glaucoma surgery has a well-documented safety profile. MIGS procedures carry the standard intraocular surgery risk (infection <0.1%, IOP spike 5-10%, hyphaema 1-2%, device malposition <2%), comparable to cataract surgery. Trabeculectomy and tube shunts carry a higher risk of bleb- or tube-related complications (5-10%) including hypotony, bleb leak and late infection — which is why filtration surgery is reserved for disease that needs a lower target pressure. Untreated progressive glaucoma is genuinely dangerous — it causes irreversible blindness. The risk-benefit calculation is strongly in favour of surgery for most patients with progressive IOP-related optic nerve damage that drops and laser have not controlled.

Can I have LASIK or refractive surgery if I have glaucoma?

It depends on your glaucoma stability. If your IOP is well controlled, your visual field is stable, and you have no advanced optic nerve damage — LASIK, SMILE or PRK can be performed safely with extra IOP monitoring. The challenge is that the corneal flap or ablation can transiently raise IOP during surgery and can reduce the accuracy of future IOP measurement (corneal thickness changes affect applanation tonometry readings). EVO ICL is often the preferred refractive option in glaucoma patients because it does not alter the cornea. Our glaucoma surgical team assesses this case-by-case and only recommends refractive surgery when the glaucoma is genuinely stable.

How long is recovery after glaucoma surgery?

Recovery varies by procedure. MIGS standalone or combined with cataract: about 1 week; vision usually clear within 24 to 72 hours. Trabeculectomy: 2 to 6 weeks of intensive review, with physical activity restricted for about 4 weeks to protect the filtering bleb. Tube shunt: similar to trabeculectomy. Most international patients stay around 5 days in Istanbul for the early post-operative reviews, then continue monitoring with their home ophthalmologist. Returning to driving is usually possible once vision and pressure are confirmed stable at review.

What are the realistic risks of glaucoma surgery?

The risks vary by procedure. MIGS: transient IOP spike, hyphaema (1–2%), device malposition (<2%), insufficient IOP reduction. Trabeculectomy: bleb leak, hypotony (low pressure), bleb infection (about 1% per year lifetime risk after the first year), accelerated cataract. Tube shunt: tube malposition, corneal endothelial cell loss, occasional double vision, late erosion. Severe sight-threatening complications are uncommon with modern technique and proper case selection. These figures are consistent with American Glaucoma Society (AGS) consensus.

Why choose Eyeglow Health over marketplace agencies for glaucoma surgery?

Glaucoma is a lifelong condition where the relationship between you and your ophthalmologist matters more than any single intervention. Marketplaces refer you to several clinics and earn a commission per referral — your file rotates between coordinators. At Eyeglow Health your case is reviewed by our own glaucoma surgical team, and surgery is performed by a glaucoma-trained ophthalmic surgeon at our partner accredited hospital. We provide a written treat-to-target IOP plan transferable to your home ophthalmologist — we are honest that lifelong monitoring is best continued at home, and we do not pretend to replace your local glaucoma specialist.
Get a free quote